These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 31786322)
41. In vitro permeation of a pegylated naltrexone prodrug across microneedle-treated skin. Milewski M; Yerramreddy TR; Ghosh P; Crooks PA; Stinchcomb AL J Control Release; 2010 Aug; 146(1):37-44. PubMed ID: 20678989 [TBL] [Abstract][Full Text] [Related]
42. Ex vivo evaluation of a microneedle array device for transdermal application. Indermun S; Choonara YE; Kumar P; du Toit LC; Modi G; van Vuuren S; Luttge R; Pillay V Int J Pharm; 2015 Dec; 496(2):351-9. PubMed ID: 26453791 [TBL] [Abstract][Full Text] [Related]
43. Swellable silk fibroin microneedles for transdermal drug delivery. Yin Z; Kuang D; Wang S; Zheng Z; Yadavalli VK; Lu S Int J Biol Macromol; 2018 Jan; 106():48-56. PubMed ID: 28778522 [TBL] [Abstract][Full Text] [Related]
44. The Influence of Microneedles on the Percutaneous Penetration of Selected Antihypertensive Agents: Diltiazem Hydrochloride and Perindopril Erbumine. Luu E; Ita KB; Morra MJ; Popova IE Curr Drug Deliv; 2018; 15(10):1449-1458. PubMed ID: 30058488 [TBL] [Abstract][Full Text] [Related]
45. Bioceramic microneedles with flexible and self-swelling substrate. Cai B; Xia W; Bredenberg S; Li H; Engqvist H Eur J Pharm Biopharm; 2015 Aug; 94():404-10. PubMed ID: 26126420 [TBL] [Abstract][Full Text] [Related]
46. Microneedles: A smart approach and increasing potential for transdermal drug delivery system. Waghule T; Singhvi G; Dubey SK; Pandey MM; Gupta G; Singh M; Dua K Biomed Pharmacother; 2019 Jan; 109():1249-1258. PubMed ID: 30551375 [TBL] [Abstract][Full Text] [Related]
47. Inkjet printing of transdermal microneedles for the delivery of anticancer agents. Uddin MJ; Scoutaris N; Klepetsanis P; Chowdhry B; Prausnitz MR; Douroumis D Int J Pharm; 2015 Oct; 494(2):593-602. PubMed ID: 25617676 [TBL] [Abstract][Full Text] [Related]
49. Polymeric microneedles for controlled transdermal drug delivery. Singh P; Carrier A; Chen Y; Lin S; Wang J; Cui S; Zhang X J Control Release; 2019 Dec; 315():97-113. PubMed ID: 31644938 [TBL] [Abstract][Full Text] [Related]
50. Spatially controlled coating of continuous liquid interface production microneedles for transdermal protein delivery. Caudill CL; Perry JL; Tian S; Luft JC; DeSimone JM J Control Release; 2018 Aug; 284():122-132. PubMed ID: 29894710 [TBL] [Abstract][Full Text] [Related]
51. Delivery of Methotrexate and Characterization of Skin Treated by Fabricated PLGA Microneedles and Fractional Ablative Laser. Nguyen HX; Banga AK Pharm Res; 2018 Feb; 35(3):68. PubMed ID: 29468316 [TBL] [Abstract][Full Text] [Related]
52. Full-Thickness Intraoral Mucosa Barrier Models for In Vitro Drug-Permeation Studies Using Microneedles. Serpe L; Muniz BV; Santos CPD; da Silva CB; Volpato MC; Groppo FC; Lopez RFV; Franz-Montan M J Pharm Sci; 2019 May; 108(5):1756-1764. PubMed ID: 30553821 [TBL] [Abstract][Full Text] [Related]
53. Microneedles for Extended Transdermal Therapeutics: A Route to Advanced Healthcare. Pahal S; Badnikar K; Ghate V; Bhutani U; Nayak MM; Subramanyam DN; Vemula PK Eur J Pharm Biopharm; 2021 Feb; 159():151-169. PubMed ID: 33388372 [TBL] [Abstract][Full Text] [Related]
54. Elastic vesicles of sumatriptan succinate for transdermal administration: characterization and in vitro permeation studies. Balaguer-Fernández C; Femenía-Font A; Merino V; Córdoba-Díaz D; Elorza-Barroeta MA; López-Castellano A; Córdoba-Díaz M J Liposome Res; 2011 Mar; 21(1):55-9. PubMed ID: 20429812 [TBL] [Abstract][Full Text] [Related]
55. Biocompatible polymer microneedle for topical/dermal delivery of tranexamic acid. A Machekposhti S; Soltani M; Najafizadeh P; Ebrahimi SA; Chen P J Control Release; 2017 Sep; 261():87-92. PubMed ID: 28645793 [TBL] [Abstract][Full Text] [Related]
56. Comparative efficacy evaluation of different penetration enhancement strategies for dermal delivery of poorly soluble drugs - A case with sertaconazole nitrate. Bubić Pajić N; Vucen S; Ilić T; O'Mahony C; Dobričić V; Savić S Eur J Pharm Sci; 2021 Sep; 164():105895. PubMed ID: 34087357 [TBL] [Abstract][Full Text] [Related]
57. Optimizing microneedle arrays to increase skin permeability for transdermal drug delivery. Al-Qallaf B; Das DB Ann N Y Acad Sci; 2009 Apr; 1161():83-94. PubMed ID: 19426308 [TBL] [Abstract][Full Text] [Related]
58. Structural characterisation and transdermal delivery studies on sugar microneedles: experimental and finite element modelling analyses. Loizidou EZ; Williams NA; Barrow DA; Eaton MJ; McCrory J; Evans SL; Allender CJ Eur J Pharm Biopharm; 2015 Jan; 89():224-31. PubMed ID: 25481031 [TBL] [Abstract][Full Text] [Related]
59. IgG-loaded hyaluronan-based dissolving microneedles for intradermal protein delivery. Mönkäre J; Reza Nejadnik M; Baccouche K; Romeijn S; Jiskoot W; Bouwstra JA J Control Release; 2015 Nov; 218():53-62. PubMed ID: 26437262 [TBL] [Abstract][Full Text] [Related]
60. Nanocomposite-strengthened dissolving microneedles for improved transdermal delivery to human skin. Yan L; Raphael AP; Zhu X; Wang B; Chen W; Tang T; Deng Y; Sant HJ; Zhu G; Choy KW; Gale BK; Prow TW; Chen X Adv Healthc Mater; 2014 Apr; 3(4):555-64. PubMed ID: 24173960 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]